WASHINGTON — A vaccination campaign to combat rotavirus in the world's poorest countries could save the lives of hundreds of thousands of children, according to a pair of studies published this week.
WASHINGTON — A vaccination campaign to combat rotavirus in the world's poorest countries could save the lives of hundreds of thousands of children, according to a pair of studies published this week.
A complete three-dose series of pentavalent rotavirus vaccine was 85 percent to 89 percent effective against rotavirus gastroenteritis severe enough to cause emergency room visits or hospital admission in children aged 15 days through 23 months.
Rotavirus is responsible for the deaths of more than 1,500 infants and children daily, mainly in developing countries. The International Medica Foundation is sponsoring a Phase II clinical trial of its oral rotavirus vaccine, RotaShield.
DAKAR, Senegal — Health experts in Africa are calling on governments to vaccinate children against rotavirus, to end an “unacceptable” yet preventable situation in which the virus kills some 1,400 children in developing countries daily
GlaxoSmithKline announced Nov. 30 that it has filed its vaccine for the prevention of rotavirus gastroenteritis (approved as Rotarix in several countries outside of Japan).